Compare Cronos Group Inc (CRON) vs Ferrari NV (RACE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs Ferrari NV — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.20B), while Ferrari NV trades at $390.29 (market cap $68.13B). The key difference: Ferrari NV is far larger — about 56.8× Cronos Group Inc's market cap, and Ferrari NV pays a 1.09% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and Ferrari NV for 126 Days on average.
| CRON | RACE | |
|---|---|---|
Market Cap | $1.20B | $68.13B |
Volume | 450,387 | 480,007 |
Sector | Health | Consumer Cyclical |
52-Week High | $3.55 | $436.54 |
52-Week Low | $2.30 | $314.63 |
Typical Hold Time | 22 Days | 126 Days |
Enterprise Value | $401.73M | $70.01B |
Dividend Yield | — | 1.09% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.24, down 1.37% on the day, with a bearish technical signal and neutral oscillators. The company reported a net loss of $9.45M in 2025 despite revenue growth to $146.59M, but recent quarters show earnings beats. Analyst sentiment is mixed with 20% buy, 60% hold, and 20% sell ratings. Recent news highlights investor day events and international expansion efforts.
The outlook is cautious; profitability improvements and cash flow generation are key catalysts, but high valuation multiples and negative net cash flow pose risks. Regulatory developments in cannabis markets and execution on growth targets will be critical for stock performance.
Ferrari (RACE) trades at $386.39, down 0.03% on the day, with a bearish technical signal but strong fundamentals. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Revenue and net income have grown steadily from 2022 to 2025, supported by robust profitability margins. Recent news highlights a share buyback program and strategic partnerships, while institutional investors show increased interest.
The outlook remains positive due to strong financial performance and analyst consensus, with a price target of $462.75 implying ~20% upside. Risks include high valuation multiples, economic sensitivity, and execution challenges in electric vehicle initiatives. The stock offers growth potential but requires monitoring of competitive and macroeconomic pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About Ferrari NV
Ferrari engineers and manufactures some of the world's most expensive exotic sports cars. The Ferrari brand is synonymous with Formula One racing, exclusivity, Italian design, and state-of-the-art technology. Ferrari also has a captive finance company that provides funding for dealers and clients.
Read more on RACE →
